Skip to main content
logo
/
Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS · Delayed Price · Currency is USD
5.69
-0.17 (-2.86%)
Jul 16, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Pharmaceutical
12.77B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-18.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Japan
6.17B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
7616.25%
Log In
Log In
Log In
Log In
Upgrade
Switzerland
4.00B
Log In
Log In
Log In
Log In
Upgrade
Switzerland Growth
56.16%
Log In
Log In
Log In
Log In
Upgrade
United States
1.37B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-86.18%
Log In
Log In
Log In
Log In
Upgrade
Bermuda
1.21B
Log In
Log In
Log In
Log In
Upgrade
Bermuda Growth
-57.46%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
4.00M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-97.18%
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
-
Log In
Log In
Log In
Log In
Upgrade